Voyager Therapeutics (MEX:VYGR) Change In Receivables : MXN47 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Voyager Therapeutics Change In Receivables?

Voyager Therapeutics's change in receivables for the quarter that ended in Mar. 2025 was MXN1 Mil. It means Voyager Therapeutics's Accounts Receivable declined by MXN1 Mil from Dec. 2024 to Mar. 2025 .

Voyager Therapeutics's change in receivables for the fiscal year that ended in Dec. 2024 was MXN1,696 Mil. It means Voyager Therapeutics's Accounts Receivable declined by MXN1,696 Mil from Dec. 2023 to Dec. 2024 .

Voyager Therapeutics's Accounts Receivable for the quarter that ended in Mar. 2025 was MXN33 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Voyager Therapeutics's Days Sales Outstanding for the three months ended in Mar. 2025 was 22.88.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Voyager Therapeutics's liquidation value for the three months ended in Mar. 2025 was MXN3,206 Mil.

Voyager Therapeutics Change In Receivables Historical Data

The historical data trend for Voyager Therapeutics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyager Therapeutics Change In Receivables Chart

Voyager Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

208.55

149.34

9.26

-1,412.84

1,695.80

Voyager Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															1,328.27	3.77	-323.26	364.72	1.43

Voyager Therapeutics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN47 Mil.

Voyager Therapeutics (MEX:VYGR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Voyager Therapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	33.204	/	132.426	*	91
=	22.88

2. In Ben Graham's calculation of liquidation value, Voyager Therapeutics's accounts receivable are only considered to be worth 75% of book value:

Voyager Therapeutics's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4828.524	-	1647.663	+	0.75 * 33.204	+	0.5 * 0
=	3,206

Voyager Therapeutics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Voyager Therapeutics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyager Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Voyager Therapeutics Inc (MEX:VYGR) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

VYGR:USA VT6:Germany

Address

75 Hayden Avenue, Lexington, MA, USA, 02421

Website

https://www.voyagertherapeutics.com

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.